Latest Breaking News On - Eton pharmaceuticals inc - Page 1 : vimarsana.com

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Short Interest Down 35.9% in May

Eton Pharmaceuticals, Inc. (NASDAQ:ETON – Get Free Report) saw a significant drop in short interest during the month of May. As of May 31st, there was short interest totalling 54,600 shares, a drop of 35.9% from the May 15th total of 85,200 shares. Approximately 0.2% of the shares of the company are short sold. Based […]

Harrow, Inc. (NASDAQ:HROW) Short Interest Down 9.5% in May

Harrow, Inc. (NASDAQ:HROW – Get Free Report) was the target of a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 4,980,000 shares, a decline of 9.5% from the April 30th total of 5,500,000 shares. Based on an average daily volume of 510,400 shares, the […]

Harrow (NASDAQ:HROW) Shares Down 5.8%

Shares of Harrow, Inc. (NASDAQ:HROW – Get Free Report) traded down 5.8% on Wednesday . The company traded as low as $17.45 and last traded at $17.49. 215,167 shares changed hands during mid-day trading, a decline of 54% from the average session volume of 464,695 shares. The stock had previously closed at $18.56. Analyst Upgrades […]

Analysts Offer Predictions for Harrow, Inc.'s Q2 2024 Earnings (NASDAQ:HROW)

Harrow, Inc. (NASDAQ:HROW – Free Report) – B. Riley dropped their Q2 2024 earnings per share (EPS) estimates for Harrow in a research report issued to clients and investors on Tuesday, May 14th. B. Riley analyst M. Mamtani now expects that the company will earn ($0.25) per share for the quarter, down from their previous […]

Harrow, Inc. (NASDAQ:HROW) Short Interest Update

Harrow, Inc. (NASDAQ:HROW – Get Free Report) was the recipient of a significant decrease in short interest in April. As of April 30th, there was short interest totalling 5,500,000 shares, a decrease of 7.1% from the April 15th total of 5,920,000 shares. Based on an average daily trading volume, of 462,100 shares, the days-to-cover ratio […]

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Short Interest Down 41.0% in April

Craig Hallum Begins Coverage on Eton Pharmaceuticals (NASDAQ:ETON)

Eton Pharmaceuticals (NASDAQ:ETON) Coverage Initiated at Craig Hallum

Eton Pharmaceuticals (ETON) to Release Earnings on Thursday

Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)

Company anticipates 10-month review for potential approval in Q1 2025 - - Eton expects ET-400 and Alkindi Sprinkle® to achieve potential combined peak sales…